Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 913

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 913
---
 on Form 8-K filed on August 9, 2024).

    19.1
     
    Insider Trading Policy.*

    21.1
     
    Subsidiaries.*

    23.1
     
    Consent of Marcum LLP, independent registered public accounting firm.*

    31.1
     
    Certification of principal executive officer pursuant to Section 3.02 of the Sarbanes-Oxley Act of 2002.*

    31.2
     
    Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

    32.1
     
    Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

    32.2

    Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

    97.1
     
    INmune
    Bio Policy for recovery of erroneously awarded compensation (incorporated by reference to Exhibit 97.1 to our Annual Report on Form
    10-K filed with the SEC on March 28, 2024).

    101.INS
     
    Inline
    XBRL Instance Document

    101.SCH
     
    Inline XBRL
    Taxonomy Extension Schema Document

    101.CAL
     
    Inline XBRL
    Taxonomy Extension Calculation Linkbase Document

    101.DEF
     
    Inline XBRL
    Taxonomy Extension Definition Linkbase Document

    101.LAB
     
    Inline XBRL
    Taxonomy Extension Label Linkbase Document

    101.PRE
     
    Inline XBRL
    Taxonomy Extension Presentation Linkbase Document

    104
     
    Cover Page
    Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Filed herewith.

**Furnished herewith.

Item 16. Form 10-K Summary

None.

72

SIGNATURES

Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

    INMUNE BIO INC.

    /s/ Raymond J. Tesi
  
    Dated: March 27,